AR008229A1 - DEVICES INTENDED FOR THE TRANSDERMIC ADMINISTRATION CONTAINING TWO ACTIVE PRINCIPLES IN SEPARATE COMPARTMENTS, THEIR MANUFACTURING PROCEDURE AND THEIR APPLICATION AS A MEDICINAL PRODUCT. - Google Patents
DEVICES INTENDED FOR THE TRANSDERMIC ADMINISTRATION CONTAINING TWO ACTIVE PRINCIPLES IN SEPARATE COMPARTMENTS, THEIR MANUFACTURING PROCEDURE AND THEIR APPLICATION AS A MEDICINAL PRODUCT.Info
- Publication number
- AR008229A1 AR008229A1 ARP970102528A ARP970102528A AR008229A1 AR 008229 A1 AR008229 A1 AR 008229A1 AR P970102528 A ARP970102528 A AR P970102528A AR P970102528 A ARP970102528 A AR P970102528A AR 008229 A1 AR008229 A1 AR 008229A1
- Authority
- AR
- Argentina
- Prior art keywords
- application
- manufacturing procedure
- medicinal product
- active principles
- separate compartments
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Abstract
Un dispositivo destinado a la administración transdérmica de dos activos (I) y (II) constituídos por dos compartimientos (A) Y (b), conteniendo elcompartimiento (A) una matriz cargada de (I), y conteniendo el compantimiento (B) una matrizcargad a de (II), estando cada una de estas matrices recubiertarespectivamente con una película de protección, de naturaleza idéntica o no, (a) y (a), caracterizado porque (A) está separado de (B) por un espacio vacíode 1 a 10mm y caracterizadoporque (A ) y (B) están soportados sobre la misma película protectora desprendible (b), su procedimiento de fabricación y suaplicación como medicamento.A device intended for the transdermal administration of two assets (I) and (II) consisting of two compartments (A) and (b), compartment (A) containing a matrix loaded with (I), and compartment (B) containing one matrix loaded with (II), each of these matrices being respectively covered with a protective film, identical or not, (a) and (a), characterized in that (A) is separated from (B) by an empty space of 1 at 10mm and characterized because (A) and (B) are supported on the same removable protective film (b), its manufacturing procedure and its application as a medicine.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9607209A FR2749514B1 (en) | 1996-06-11 | 1996-06-11 | TRANSDERMAL SYSTEMS CONTAINING 2 ACTIVE INGREDIENTS IN SEPARATE COMPARTMENTS, THEIR PREPARATION METHOD AND THEIR APPLICATION AS A MEDICAMENT |
Publications (1)
Publication Number | Publication Date |
---|---|
AR008229A1 true AR008229A1 (en) | 1999-12-29 |
Family
ID=9492920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970102528A AR008229A1 (en) | 1996-06-11 | 1997-06-10 | DEVICES INTENDED FOR THE TRANSDERMIC ADMINISTRATION CONTAINING TWO ACTIVE PRINCIPLES IN SEPARATE COMPARTMENTS, THEIR MANUFACTURING PROCEDURE AND THEIR APPLICATION AS A MEDICINAL PRODUCT. |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0904086B1 (en) |
JP (1) | JP2000511921A (en) |
CN (1) | CN1119150C (en) |
AR (1) | AR008229A1 (en) |
AT (1) | ATE284215T1 (en) |
AU (1) | AU739141B2 (en) |
BR (1) | BR9715082A (en) |
CA (1) | CA2257913A1 (en) |
CZ (1) | CZ295350B6 (en) |
DE (1) | DE69731883T2 (en) |
ES (1) | ES2235236T3 (en) |
FR (1) | FR2749514B1 (en) |
NO (1) | NO320999B1 (en) |
PL (1) | PL189361B1 (en) |
RU (1) | RU2209090C2 (en) |
TR (1) | TR199802577T2 (en) |
TW (1) | TWI228999B (en) |
WO (1) | WO1997047305A1 (en) |
ZA (1) | ZA975160B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200306196A (en) * | 2002-04-03 | 2003-11-16 | Wyeth Corp | Hormone replacement therapy |
DE10220230A1 (en) * | 2002-05-06 | 2003-11-27 | Sanol Arznei Schwarz Gmbh | Use of Rotigotine to treat restless leg syndrome |
US8343538B2 (en) | 2004-10-08 | 2013-01-01 | Noven Pharmaceuticals, Inc. | Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems |
DE102005034498A1 (en) * | 2005-07-20 | 2007-01-25 | Grünenthal GmbH | Oral contraception with Trimegeston |
WO2007076144A2 (en) | 2005-12-27 | 2007-07-05 | Duramed Pharmaceuticals, Inc. | Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
US20080226698A1 (en) * | 2007-03-16 | 2008-09-18 | Mylan Technologies, Inc. | Amorphous drug transdermal systems, manufacturing methods, and stabilization |
US8491927B2 (en) | 2009-12-02 | 2013-07-23 | Nimble Epitech, Llc | Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
US10821297B2 (en) * | 2016-09-30 | 2020-11-03 | Johnson & Johnson Consumer Inc. | Kit and method for topical delivery of benefits |
JP6982960B2 (en) * | 2017-02-07 | 2021-12-17 | リンテック株式会社 | Packaging and packaging |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2430953A1 (en) * | 1978-07-13 | 1980-02-08 | Roussel Uclaf | NOVEL 3,20-DIOXO 4,9-DIENE 21-HYDROXYL DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS |
DE3714140A1 (en) * | 1987-04-28 | 1988-11-10 | Lohmann Therapie Syst Lts | ACTIVE SUBSTANCE PLASTER FOR THE CONTROLLED ADMINISTRATION OF ACTIVE SUBSTANCES TO THE SKIN, ITS USE AND METHOD FOR THE CONTROLLED ADMINISTRATION OF ACTIVE SUBSTANCES TO THE SKIN |
US5788983A (en) * | 1989-04-03 | 1998-08-04 | Rutgers, The State University Of New Jersey | Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes |
DE4227989A1 (en) * | 1992-08-21 | 1994-06-09 | Schering Ag | Agent for transdermal application containing 3-keto-desogestrel |
-
1996
- 1996-06-11 FR FR9607209A patent/FR2749514B1/en not_active Expired - Fee Related
-
1997
- 1997-06-10 AR ARP970102528A patent/AR008229A1/en active IP Right Grant
- 1997-06-10 DE DE69731883T patent/DE69731883T2/en not_active Expired - Fee Related
- 1997-06-10 RU RU99100390/14A patent/RU2209090C2/en not_active IP Right Cessation
- 1997-06-10 CN CN97197162A patent/CN1119150C/en not_active Expired - Fee Related
- 1997-06-10 BR BR9715082-7A patent/BR9715082A/en not_active IP Right Cessation
- 1997-06-10 AU AU32661/97A patent/AU739141B2/en not_active Ceased
- 1997-06-10 JP JP10501289A patent/JP2000511921A/en not_active Abandoned
- 1997-06-10 CZ CZ19984108A patent/CZ295350B6/en not_active IP Right Cessation
- 1997-06-10 PL PL97330597A patent/PL189361B1/en not_active IP Right Cessation
- 1997-06-10 TR TR1998/02577T patent/TR199802577T2/en unknown
- 1997-06-10 ES ES97928318T patent/ES2235236T3/en not_active Expired - Lifetime
- 1997-06-10 WO PCT/FR1997/001024 patent/WO1997047305A1/en active IP Right Grant
- 1997-06-10 EP EP97928318A patent/EP0904086B1/en not_active Expired - Lifetime
- 1997-06-10 AT AT97928318T patent/ATE284215T1/en not_active IP Right Cessation
- 1997-06-10 CA CA002257913A patent/CA2257913A1/en not_active Abandoned
- 1997-06-11 ZA ZA9705160A patent/ZA975160B/en unknown
- 1997-06-16 TW TW086108355A patent/TWI228999B/en not_active IP Right Cessation
-
1998
- 1998-12-11 NO NO19985807A patent/NO320999B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ATE284215T1 (en) | 2004-12-15 |
EP0904086A1 (en) | 1999-03-31 |
CZ295350B6 (en) | 2005-07-13 |
DE69731883D1 (en) | 2005-01-13 |
TR199802577T2 (en) | 1999-03-22 |
FR2749514A1 (en) | 1997-12-12 |
AU739141B2 (en) | 2001-10-04 |
DE69731883T2 (en) | 2005-12-22 |
RU2209090C2 (en) | 2003-07-27 |
ES2235236T3 (en) | 2005-07-01 |
BR9715082A (en) | 2003-07-15 |
CA2257913A1 (en) | 1997-12-18 |
PL189361B1 (en) | 2005-07-29 |
CN1227492A (en) | 1999-09-01 |
TWI228999B (en) | 2005-03-11 |
NO985807D0 (en) | 1998-12-11 |
EP0904086B1 (en) | 2004-12-08 |
AU3266197A (en) | 1998-01-07 |
CZ410898A3 (en) | 1999-09-15 |
ZA975160B (en) | 1998-06-11 |
JP2000511921A (en) | 2000-09-12 |
WO1997047305A1 (en) | 1997-12-18 |
NO320999B1 (en) | 2006-02-27 |
NO985807L (en) | 1999-02-10 |
PL330597A1 (en) | 1999-05-24 |
FR2749514B1 (en) | 1998-08-07 |
CN1119150C (en) | 2003-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT8719064A0 (en) | TABLET FOR PHARMACEUTICAL USE SUITABLE FOR THE RELEASE OF ACTIVE SUBSTANCES AT SUBSEQUENT TIMES. | |
KR890701076A (en) | Temperature-controlled active drug dispenser | |
DE3853526D1 (en) | Active thin film matrix and associated addressing circuit. | |
ES2140658T3 (en) | TRANSDERMIC THERAPEUTIC SYSTEMS CONTAINING SEXUAL STEROIDS. | |
DZ1530A1 (en) | Pharmaceutical composition in gel form in dispenser packaging. | |
AR002754A1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING MICRO-ENCAPSULATED VIABLE LACTOBACILLUS BACTERIA, AND USE OF THE COMPOSITION TO PREPARE A MEDICINAL PRODUCT | |
DE3868766D1 (en) | DISPLAY DEVICE OF THE ACTIVE MATRIX TYPE. | |
FI940427A0 (en) | Transdermal therapeutic systems | |
ITMI922192A1 (en) | COMPRESSED FOR THERAPEUTIC USE SUITABLE FOR SELLING ONE OR MORE ACTIVE SUBSTANCES WITH DIFFERENT SPEEDS | |
DE69126270T2 (en) | Transdermal therapeutic preparations | |
ES2041988T3 (en) | DEVICE COMPRISING MEANS TO PROTECT AND SUPPLY SENSITIVE AND FLUID MEDICINAL PRODUCT. | |
ES2060825T3 (en) | A THERAPEUTIC SYSTEM FOR DELAYED AND CONTROLLED ADMINISTRATION OF ACTIVE SUBSTANCES BY VIA PERCUTANEA OR THROUGH THE MUCOSA. | |
KR880009639A (en) | Sustained Release Matrix Formulations | |
AR008229A1 (en) | DEVICES INTENDED FOR THE TRANSDERMIC ADMINISTRATION CONTAINING TWO ACTIVE PRINCIPLES IN SEPARATE COMPARTMENTS, THEIR MANUFACTURING PROCEDURE AND THEIR APPLICATION AS A MEDICINAL PRODUCT. | |
ITRM910402A0 (en) | ITEM CONTAINING MEDICINES AND DELIVERY DEVICE FOR THEM. | |
CO5011082A1 (en) | DRUG FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE | |
ES2021167B3 (en) | DERIVATIVES OF PIRAZOLE AND INSECTICIDES, MITICIDES AND FUNGICIDES CONTAINING THEM, AS AN ACTIVE INGREDIENT | |
DE68917651T2 (en) | Active matrix display device. | |
ATE450254T1 (en) | FLOATING PHARMACEUTICAL COMPOSITION HAVING AN ACTIVE PHASE AND AN INACTIVE PHASE | |
NO881109D0 (en) | MEDICINE FOR INSECT AND MIDDLE PROTECTION. | |
MX24039A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN AS AN ACTIVE SUBSTANCE. | |
ES2060708T3 (en) | THERAPEUTIC DELAYED RELEASE SYSTEM FOR LIQUID PHARMACEUTICAL FORMULATIONS. | |
DE3770766D1 (en) | ACTIVE SUBSTANCES FOR TUMOR TREATMENT. | |
DE69013610T2 (en) | Active matrix display device. | |
AR013580A1 (en) | DEVICES FOR THE TRANSDERMAL ADMINISTRATION OF TRIMEGESTONE, ITS PREPARATION AND ESTERES PROCEDURE IN THE POSITION 21 OF THE TRIMEGESTONE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |